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THE PLIGHT OF ONCOLOGISTS: BURNOUT AND BIOTECHNOLOGY 
 
CATHERINE SCHIRMERS 
ABSTRACT 
 The current state of medical training and practice is not beneficial for the patients 
nor the physicians: the only participants profiting from the existing disconnect are the 
pharmaceutical companies.  In regards to oncology, there are specific problems present in 
their field felt more deeply than other specialties.  This literature review will assess the 
current studies regarding methods of burnout and the impact of biotechnology, 
specifically pharmaceutical costs and the excess of information, in the practice of 
oncology.   
Oncologists suffer from one of the highest amounts of burnout, which is stress 
that results from the fragile interaction between the physician and their dying patients.  
The involvements with people, job setting, personal characteristics, and end of life care 
discussions are some of the job facets that cause higher amounts of burnout.  
Additionally, the costs of oncological drugs and the physicians’ attempts to analyze the 
cost-effectiveness of treatment also add to the stress felt by oncologists.  Finally, the 
professional duty to maintain an extensive knowledge base of recently published data has 
resulted in information overload. 
Findings suggest multiple ways to reduce burnout rates, which are discussed in 
length.  In regards to end of life care, there are communication changes physicians can 
make to improve the discourse for the benefit of the patient and physician.  Literature has 
also presented ways for oncologists to combat the cost of cancer care not only by 
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challenging the pharmaceutical companies, but also by ensuring their treatment and test 
choices are backed by evidence-based data.  Finally, various methods to consolidate the 
influx of information have been suggested in addition to teaching medical students how 
to assess quality in the midst of quantity. 
All of the examined literature investigating the aforementioned plights of 
physicians, with a focus on the specialty of oncology, supports the need for a change 
within the medical profession.  Specifically, this modification to the approach of patient 
care and physician welfare should be addressed starting in medical school.  Through the 
application of the suggestions in this review, physicians would be upholding the 
Hippocratic Oath more stringently, thus benefiting the patients and their own vocation.    
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INTRODUCTION 
 
 The patients restlessly inquire for the third time whether the doctor, who is an 
hour late, will be gracing their presence any time soon. Meanwhile, the oncologist 
informs his or her loved ones in between appointments that he or she is detained at the 
office longer than anticipated, and will be arriving home late yet again. Furthermore, 
when delivering a terminal diagnosis to the vulnerable patient in front of them, the 
physician tries to divulge the necessary information to reassure and support them, all 
while trying to deduce how to move onto the next appointment without seeming crass.  
While physicians understand that this profession requires them to put their patients before 
their personal life, the training does not adequately prepare them for the hardships faced 
in practice.  
The delicate balance of biological, psychological, and sociological factors 
required for proper welfare in human beings can be thoroughly disrupted by a stressful 
work life (Tanriverdi, 2013). Being a physician requires a certain level of emotional 
sensitivity; for oncologists, the high intensity of connection with their patients eventually 
depletes their ability to create an indispensable bond that is helpful for patient care.  In 
1974, Herbert Freudenberger formally introduced the concept of ‘burnout,’ which 
contains three components: emotional exhaustion, depersonalization (treating people in 
an unfeeling, impersonal way), and low personal accomplishment.  While stress was 
defined in 1956 as a “non-specific reaction showed by the individual when he [or she] has 
to face a demand or adapt to a new event,” burnout specifically refers to stress that stems 
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from the social interface between helper and recipient (Szabo, Tache, & Somogyi, 2012; 
Maslach, 1982). The overwhelming emotional burden leads to oncologists retreating from 
personal involvement, and the burnout can manifest through many different signs and 
symptoms both individually and in team settings (Table 1) (Kearney MK et al., 2009). 
Their reduction in patient contact, in hopes to restore their own psychological needs, 
changes their entire view of their job requirements: “by applying a formula [to the 
patients], rather than a unique response, they avoid having to get to know the other 
person and becoming emotionally involved” (Maslach, 1982, p. 3). While the patients 
accuse oncologists of being money-driven individuals, it is actually the fervent 
commitment and caring of physicians that leads to their demise (Rosenthal, 2014). 
 
Table 1. Symptoms and Signs of Burnout.  Taken from Kearney MK et al., 2009.
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Burnout is not a problem associated with a specific culture: the burden of 
oncologists infiltrates all hospitals, doctor’s offices, and private practices with no regard 
to social factors. Physicians have been surveyed in many different countries: Australia, 
Italy, France, Brazil, Venezuela, Serbia, Canada, and the United States (Belgrade, 2000; 
Glasberg et al., 2007; Grunfeld et al., 2000; Schraub & Marx, 2004; Stafford & Judd, 
2010; Torres & Guarino, 2013; Whippen & Canellos, 1991). In almost every study cited, 
at least one third of participants suffered from debilitating job stress derived from 
burnout. No matter the cultural differences, burnout is a universal language understood 
by most physicians at some point during their career.  
The challenges associated with the practice of oncology do not only stem from 
patient interactions, but also from the ever-changing presence of biotechnology.  The 
functions of biotechnology in oncology can be seen in a variety of areas: molecular 
biology, oncogenomics, sequencing, oncoproteomics, biomarkers, molecular diagnostics, 
immunotherapy, monoclonal antibodies, nanooncology, cell therapy, gene therapy, 
RNAi, microRNA, personalized therapies, drug discovery, development, and delivery 
(Jain, 2014).  While the previous list seems overwhelming, it is only the platform for 
innovation: the associated drugs, costs, and necessary knowledge expand every year as 
new drugs are developed (Figure 1) (Mullard, 2016).  Out of the yearly drug approvals, 
around 30% have been oncological drugs for the past four years: 33% in 2012, 30% in 
2013, 22% in 2014, and 31% in 2015 (Mullard, 2013-2016).  This has translated to over 
one billion dollars in oncology and immunology therapeutic drug sales in 2015 
worldwide (Figure 2) (Herper, 2015). 
 4 
Figure 1.  Novel FDA Drug Approvals Since 1993.  New molecular entities (NMEs) and Biologics License 
Applications (BLAs).  Taken from Mullard, 2016. 
 
Figure 2.  Worldwide Sales by Therapeutic Area 2013-2020.  Data is from Defined Health.  Taken from Herper, 
2015. 
  
The oncology drugs do not only demand an understanding of their clinical 
applications, but are also accompanied by an exorbitant price tag.  While physicians 
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struggle with determining the cost-effectiveness of a treatment, the patients have attached 
a negative label to the profession: “Many specialists have become particularly adept at 
the business of medicine by becoming more entrepreneurial, protecting their turf through 
aggressive lobbying by their medical societies, and most of all, increasing revenues by 
offering new procedures — or doing more of lucrative ones” (Rosenthal, 2014).  A level 
of trust has to be placed in the doctor for the patient to accept that the recommended 
drugs and treatment are necessary, and they are not being ordered for the profit of the 
physician. 
 After being given the diagnosis of cancer, some patients emotionally shut down 
and stop listening.  The majority cannot understand the associated lexicon nor do they 
want to accept what the tests and biopsies have confirmed.  At that moment, their only 
option is to entrust their fate to an oncologist, whom they hope takes into account their 
individual, familial, and socioeconomic concerns.  A single patient and his or her worries 
are only part of a large caseload, all of whom want the same thing: a life after cancer.  
Oncologists must learn to navigate their career more adeptly in order to better understand 
the needs of each patient in addition to balancing their own burnout and maintaining a 
knowledge base of the current biotech industry.  Changes in various areas of medical care 
and education must occur to facilitate not only a better experience for worried patients, 
but also for the welfare of overworked physicians.  
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Specific Aims and Objectives 
 Through this literature review, the methods of burnout and the burden of 
biotechnology in regards to pharmaceutical drug costs and information overload on the 
professional and personal lives of oncologists will be thoroughly assessed.  After 
analyzing the current published data, techniques for burnout reduction, cost reduction, 
and consolidation of information will be discussed.  Subsequently, recommendations 
regarding necessary changes to medical training and technology will be concluded. 
.  
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PUBLISHED STUDIES 
Causes of Burnout  
In a study performed by Stafford & Judd, data was compiled from oncologists 
practicing different specialties in various countries to analyze their response to a 12-item 
General Health Questionnaire (GHQ), which defined psychological morbidity as a score 
greater than four, and the Maslach Burnout Inventory (MBI), which assess emotion 
exhaustion (EE), depersonalization (DP), and personal accomplishment (PA) (Table 2). 
They note that burnout is not only specific to oncology, but is also experienced by other 
physicians as well (Table 2). However, there are some unique aspects created by facing 
death on a daily basis that increase the emotional encumbrance carried by oncologists, 
which are explored in a later section.  
 
Table 2. Occupational burnout and psychological morbidity by medical specialty.  Taken from Stafford and 
Judd, 2010.
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As seen in their results, medical oncologists in Canada seem to be facing the 
highest combination of psychological morbidity and burnout with 53.3% of respondents 
facing EE and 48.4% reporting low levels of PA (Table 2).  Within those individuals, 
there is a statistical significance between the percent of physicians that stated they have 
considered leaving for a job outside of Ontario, reducing the number of hours worked, 
and taking early retirement compared to allied health professionals and support staff 
(Table 3) (Grunfeld et al., 2000). Notably, changing to a job outside of the cancer care 
system was appealing to all three groups: 39.3%, 37.1%, and 30.5%, respectively (Table 
3). Physicians had wrongly assumed the burnout rates of oncologists in Canada “and 
other countries wherein universal health care—thus, absent dealing with insurance 
company merchants—and minimal malpractice litigation abide” would have been 
significantly different from American oncologists (“The psychology of oncology,” 2008).  
 
Table 3. Proportion of respondents considering alternative work situations.  Taken from Grunfeld et at., 2000.
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Due to the vast prevalence of burnout among oncologists worldwide, there are 
underlying commonalities felt by many who enter the oncology ward that lead to 
emotional exhaustion, depersonalization, and low personal accomplishment: lack of time 
devoted to research, quality of life (QOL), case load, and age (Table 4) (Kuerer et al., 
2007). To offer any solutions, the sources have to be analyzed. Involvement with people, 
the job setting, personal characteristics, and end of life (EOL) care all encompass specific 
tribulations that will be thoroughly examined.  
 
Table 4. Factors independently associated with burnout among the 549 members of the Society of Surgical 
Oncology who participated in the survey study.  Taken from Kuerer et al., 2007.
 
 
Involvement with People  
While working with and caring for people are the main reasons most choose the 
medical field, patients can be a large source of distress for medical professionals. Over 
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half of oncologists surveyed by Whippen and Canellos admitted that their burnout came 
from a feeling of failure and frustration, and that this was an intrinsic predicament of their 
job choice (Penson, Dignan, Canellos, Picard, & Lynch, 2000; Whippen & Canellos, 
1991). In addition, Christina Maslach noted that caregivers “hear complaints or criticisms 
about the job they are doing, they may be blamed for not giving enough help, and in 
some instances they are the targets of hostile remarks or even threatening actions” 
(Maslach, 1982, p. 19). When dissatisfied patients thwart the help of the oncologist, or 
their suggested treatment fails not only the cancer patient, but also the family members, 
the feeling of failure and frustration noted in the survey has an understandable basis.  
Researchers have also examined the distinctive variations between oncologists 
practicing in Britain versus the United States. The job of the oncologist in the U.S. has 
two components: being both the oncologist and the ‘total care’ physician to their patients 
(Penson, Dignan, Canellos, Picard, & Lynch, 2000). In Britain, after diagnosed by the 
medical oncologist, the patient is referred to their general practitioner, who has 
continuously been responsible for their medical well being. Due to the different job 
criteria, British oncologists spend less time dealing with death, dying, and distressed 
families on a frequent basis. Therefore, U.S. physicians functioning in full-time practices 
suffer more burnout than their British counterparts (Penson, Dignan, Canellos, Picard, & 
Lynch, 2000).  
Much like the British oncologists, physicians that show variety in their medical 
interests also experience greater job satisfaction (Balch, Shanafelt, Sloan, Satele, & 
Kuerer, 2011; Kuerer et al., 2007). Oncologists that dedicated less than 25% of their time 
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to research, and hence decreased their time spent on non-patient care activities within the 
medical realm, reported increased burnout. Another factor found in medical professionals 
with higher job satisfaction was that their practice was based at an academic location 
(Balch, Shanafelt, Sloan, Satele, & Kuerer, 2011). Physicians in academic practices noted 
that they are able to alleviate their amount of work through the support of residents, 
fellows, health care team, or nurse practitioners that serve as reinforcement as they 
handle calls, patients, and family members (Halperin, 1997).  
Doctors, especially oncologists, want to be connected to their patients, but this 
specialty causes them “to grieve and die with every patient” (Tanriverdi, 2013, p. 2). All 
of this research leads to the conclusion that increased involvement with people decreases 
the satisfaction of the oncologist, but there are more aspects of the job to be considered. 
The doctor-patient relationship does not exist in a vacuum: it transpires in a work 
environment.  
Job Setting  
Anyone in the American medical field has perceived that the health care system is 
distinguished by “two goals that are often in conflict: providing health care to the sick 
and generating income” (Iglehart, 1999). Doctors feel a greater pressure to increase their 
patient load, even as the reimbursement and time per individual decreases (Penson, 
Dignan, Canellos, Picard, & Lynch, 2000). The physicians are fully aware of the 
problems surrounding a doctor’s visit, but they lack the power to instigate change:  
I mean you haven't injected them with anything but you've taken the time to talk 
with them. The whole system, and the reimbursement system in particular, is built 
against giving us time. The reimbursement system is completely warped. If you 
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can convince someone that the disease is too far advanced and all that 
chemotherapy is going to do is make them miserable, you have done a human 
being a favor. But that takes a lot of time and costs you money (Penson, Dignan, 
Canellos, Picard, & Lynch, 2000, p. 429).  
 
The patients are not willing to accept, nor should they have to, 10-15 minute 
consultations, and the oncologists do not have the ability nor the desire to intensify their 
workload as their pay decreases (“Cancer Doctors and Burnout”).  
When there is too great a volume of work and an insufficient number of 
employees, there are essential problems created in physician’s office: stressful deadlines, 
struggle with demands on time, and interference of personal life due to extended 
occupational hours (“Cancer Doctors and Burnout”). Oncologists have also commented 
that due to the multispecialty group practices, their fellow physicians decline to see each 
other’s patients since they tend to view their work as individual caseloads rather than 
shared ones (Maslach, 1982). This issue leads to the inability of the doctors to have any 
relief from work, and again increases their burnout because they are not able to escape 
their emotional burden (Penson, Dignan, Canellos, Picard, & Lynch, 2000).  
Consequently, their workplace environment can hinder oncologists with the best 
intentions and those who have a good rapport with their patients. There is a complexity of 
reciprocating factors in the job setting that can lead to burnout: “provider and coworkers; 
the provider and supervisors; the supervisors and those to whom they are accountable; the 
interplay between provider, other staff, and the rules, goals, and status of the institution; 
and, finally, the context of the institution within the larger community” (Maslach, 1982, 
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p. 53). The precarious balance can be easily overturned causing oncologists to disengage 
from their practice.  
Personal Characteristics  
In addition to involvement with people and the work place as sources of burnout, 
there are many inherent personal characteristics that have demonstrated a positive 
correlation with symptoms and signs of burnout. Understanding the particular 
demographic features and personality traits of oncologists can help better predict who is 
more susceptible. 
Between male and female physicians, females tend to experience higher levels of 
burnout (“Cancer Doctors and Burnout;” Maslach, 1982; McMurray et al., 2000). 
Researchers have suggested this difference is due to the willingness of women to become 
emotionally involved with others, while men tend to be more reserved in their contact 
and therefore display depersonalization (Maslach, 1982). While females do have a greater 
sense of demoralization and a decreased sense of achievement, those with children can 
reduce their chance of experiencing burnout by 40% when they are given the support of 
colleagues, partners, or significant others in balancing work and family matters 
(McMurray et al., 2000). Professional caregivers with families in general report less 
amounts of burnout for a variety of reasons: “older, more stable, psychologically mature 
individuals...more experienced in dealing with personal problems and emotional 
conflicts...and the family is often an emotional source rather than an emotional drain” 
(Maslach, 1982, p. 60-61).  
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In addition to gender, age is related to job satisfaction and burnout. In multiple 
studies, researchers have concluded that oncologists younger than 50 years old, or 
younger age groups in general, are more prone to burnout (Kuerer et al., 2007; Penson, 
Dignan, Canellos, Picard, & Lynch, 2000). Many might assume the difference between 
the younger and older generations of physicians is purely due to the amount of time spent 
on the job. However, the concept of ‘older but wiser’ is very apt in this circumstance: 
those oncologists tend to be more established, mature, and their perspective on life is 
balanced in comparison (Maslach, 1982). In addition, those who have been in their 
position longer have probably experienced burnout earlier on in their career, and have 
learned to better cope with burnout to excel in their field (Maslach, 1982). Unfortunately, 
those who are younger also tend to be single, which is the group that suffers the highest 
burnout in regards to marital and family status assessment (Maslach, 1982; Ramirez, 
Graham, Richards, Gregory, & Cull, 1996; Whippen & Canellos, 1991).  
There are central personality characteristics that, when assessed together, create a 
composite portrayal of an oncologist at risk for burnout. Having low esteem and 
confidence leads to a persona that is not capable of taking control and initiating change 
when necessary; instead, these individuals are apt to accept their surroundings, no matter 
how dire (Maslach, 1982). In the same realm, oncologists that seek approval from others 
rather than themselves place their self-satisfaction in the hands of their colleagues and 
patients, and can easily burnout while trying to achieve the impossible by pleasing 
everyone. Hence, those who have high autonomy consider themselves to be self-reliant 
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and are able to focus more on their own needs and psychological well being (Maslach, 
1982).  
However, Freudenberger warned that authoritarian individuals could undergo 
higher job stress due to their need for complete control and lack of delegation 
(Freudenberger, 1974). The sense of compulsiveness within these oncologists can have 
dire effects: “when present in conjunction with other characteristics of overly controlled 
emotions and low need for relaxation and pleasure, makes the medical student, and later 
the physician, more vulnerable than others to depression, alcoholism, psychiatric 
disorders, and suicide” (Kash & Holland, 1989 p. 650; Creagan, 1993). An oncologist 
even noted that the overworked physician usually creates their stress due to high 
workloads: “we start dancing to a tune that you are called to play by yourself” (“Cancer 
Doctors and Burnout,” p. 3).  Therefore, the job stress compounds levels of burnout, 
which can eventually lead to a significant decrease in both professional and personal 
welfare. 
End of Life Care 
 While the personal characteristics of physicians differ, all oncologists eventually 
have to speak with dying patients regarding end of life (EOL) care.   This type of care 
evokes many stressors that lead to burnout such as “a sense of failure or frustration when 
a patient’s illness progresses, feelings of powerlessness against illness and its associated 
losses, role conflicts and ambiguity, and the failure to enable a good death” (Asai et al., 
2007).  However, studies have shown that when oncologists can move their focus from 
treatment of the cancer to palliative care of the patient, the patients live longer and have 
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subjectively improved lives (Duska, 2015).  It has also been suggested that physicians 
need to change the way EOL care is viewed: “The decision to end treatment, if it comes, 
is not a failure, either of the patient or the physician, but instead should be viewed as a 
natural segment of the journey and a desirable change in the focus of care” (Duska, 
2015).  A patient’s quality of life may be persevered through necessary conversations 
concerning EOL care, which in turn could decrease the amount of burnout felt by the 
oncologist. 
 However, oncologists have reported a lack of training to produce quality end of 
life care: from a survey of over 6000 oncologists in 1998, “fewer than one third of 
oncologists reported that their formal training was ‘very helpful’ in communicating with 
dying patients or transitioning goals of care, and over half reported using ‘trial and error’ 
as one important source of learning about EOL care” (Jackson et al., 2008).  Studies have 
also shown that oncologists were reluctant in disclosing prognosis information in order to 
preserve patient hope (Gordon & Daugherty, 2003).  Additionally, oncologists have a 
tendency to avoid the use of percentages to communicate the prognosis for incurable 
cancer.  Consequently, oncologists struggle between the need to divulge EOL 
information with ensuring patients have “realistic expectations” about treatment options 
(Gordon & Daugherty, 2003).  Even though the technology in the medical field has 
become more sophisticated, the EOL doctor-patient conversation has stalled in 
proficiency with physicians noting a lack of concrete method of approaching the 
discussion.   
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To better understand the development of EOL communication skills, Gillett et al. 
conducted a qualitative focus groups comprised of nursing and medical students at a 
London University.  The participants noted various extrinsic and intrinsic barriers and 
facilitators that influenced their clinical practice with dying patients and their families 
(Figure 3) (Gillett et al., 2016).  Unfortunately, the medical students noted that it was 
assumed nurses were more adept at EOL care communication, which became part of the 
professional culture: “[the medical student] was actually told by one of the doctors when 
[his] patient passed away, to go speak to the intensive care nurses because they are the 
best at communications” (Gillett et al., 2016).  Additionally, another issue faced by the 
students was gatekeeping: they felt as if “qualified nurses” either kept them away to 
protect the patients or to shelter the students from death, the latter causing a fear of the 
unknown and their own inevitable reaction to death (Gillett et al., 2016). 
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Figure 3. Factors influencing EOL care Discussions.  Taken from (Gillett, O’Neill, & Bloomfield, 2016).   
 
The researchers suggest, “if end-of-life communication was included as a 
specified clinical learning outcome and therefore an unmistakably legitimate part of their 
learning, students' motivation to interact with dying patients might increase” (Gillett et 
al., 2016).  Additionally, facilitated reflective discussions after participating in such 
clinical experiences should become a commonplace feature in both nursing and medical 
programs.  The hope of such studies is to determine how to properly implement the hard 
facets of medical care into the curriculum in order to create more learning and discussion 
opportunities so issues such as EOL communication do not result in physician burnout.   
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 Since most physicians lack a useful formal communication training, oncologists 
were asked to describe their method of communication about EOL care with their most 
recent inpatient death in a qualitative study, two variations of physicians emerged: those 
who immersed themselves in both the biomedical and psychosocial aspects of care and 
those who only tended to the biomedical role (Jackson et al., 2008).  A male oncologist 
representing the former type noted, “If you think that you are curing people, in oncology 
you are going to be miserably disappointed and in 10 years you are worn out. If you are 
caring for them, you’ll succeed all the time” (Jackson et al., 2008).  However his 
counterpart concluded that the physician’s sole responsibility was curing the patient, 
commenting that “nurses [were] more in the caring mode;” therefore, he removed himself 
from the responsibility to care (Jackson et al., 2008).  This fundamental difference in type 
of treatment led to disparities in ability of competent communication, and, subsequently, 
job satisfaction as well as burnout (Figure 4) (Jackson et al., 2008). 
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Figure 4. Conceptual Map of Perceived Physician Role During End of Life Care.  Depending on the physician’s 
end of life communication skills, the result of the end of life care can either increase job satisfaction or increase 
burnout.  Taken from Jackson et al., 2008. 
 
The oncologists with the broader care model “focused on the communication 
process as a central aspect of care,” leading to a clearer method of patient and family 
interactions about the transition to EOL care (Jackson et al., 2008).  While the approach 
of each individual oncologist fluctuated, there were common qualities of communication:  
(1)The belief that conversations are a process; (2) a sense of responsibility for 
making recommendations; (3) the use of an individualized approach that took into 
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account the patient’s and family’s value system; and (4) the use of 
experimentation, reflection, and role models in the development of their 
communication method (Jackson et al., 2008). 
 
The ability to communicate clearly with patients regarding goals and expectations of 
EOL care, while taking into account the individual psychosocial state, was also 
associated with closer relationships to the patient, collegial support, fewer bone marrow 
transplant related deaths (1 versus 4), more years in practice (14 versus 9), and 
satisfaction with the provided EOL care (Figure 1) (Jackson et al., 2008). 
 However, the oncologists encompassing solely the biomedical role not only 
reported a lack of a clear method of communication, but also feeling a sense of failure at 
disease control (Jackson et al., 2008).  Through their communications, the doctors did not 
believe they could adequately effect psychosocial change nor did they make many 
treatment option recommendations, resulting in higher levels of burnout (Figure 1) 
(Jackson et al., 2008). Correspondingly, patients who were treated by these types of 
oncologists reported, “higher levels of emotional distress, hopelessness, and anxious 
preoccupation” (Meggiolaro et al., 2015).  These findings represent a need for a 
standardized method of communication to help both the patient and physician approach 
end of life care.   
 Similarly, the correlation between inability to effectively communicate with 
patients and burnout was also a finding in a study conducted by Asai et al. in Japan.  
They utilized a cross sectional nationwide survey to assess burnout and psychiatric 
morbidity in clinical oncologists and palliative care physicians.  The results suggested, 
“physician confidence in having sufficient time to communicate with patients was the 
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factor most strongly associated with burnout” (Asai et al., 2007).  Specifically, the 
oncologists felt they were unable to successfully assess the mental state of the patient 
through their limited allotted time for communication; therefore they were incapable of 
suggesting proper psychological care, preventing a sense of personal accomplishment.  
Asai et al. suggest that rather than direct involvement in EOL care, it was specific 
aspects, such as confidence in proper psychological care for the patients, which correlate 
to oncology burnout.  This corresponds to the finding of Jackson et al. that physicians 
without a clear method of communication did not feel as if they could enact psychosocial 
change, consequently creating a sense of personal failure.  Regardless of the country, the 
inability to productively communicate with patients permeates the medical culture. 
The combinatorial presence and effect of involvement with people, work 
environment, personal characteristics, and end of life care gives rise to burn out in 
oncologists: emotional exhaustion, depersonalization, and low personal accomplishment. 
As noted, there are real dangers associated with this increasing phenomenon that are felt 
by not only the physician, but also the patient: “[the oncologists] distanced themselves 
and withdrew from patients as the patients got closer to dying. This meant fewer visits in 
the hospital, fewer bedside visits and less overall effort directed toward the dying patient” 
(Granek, 2012, p.1; Granek, Mazzotta, Tozer, & Krzyzanowska, 2012). The grief mounts 
in the doctors without a proper outlet, and this has caused oncologists to suggest more 
radical treatment plans with the futile hope that they might be able to finally save a 
patient, when palliative care would have been a better option (Granek, Mazzotta, Tozer, 
& Krzyzanowska, 2012).  Chastek et al. have shown that the mean cancer-related EOL 
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care costs in the last six months were $74, 212, noting that inpatient care costs in the last 
month increased from $1,785 to $20,559.  The researchers suggest that many of the costs 
could be reduced with “proactive management of unrealistic expectations,” referencing, 
“at least 20% of patients with solid tumors receive chemotherapy within two weeks of 
dying” (Chastek et al., 2012).  This feeling of failure associated with burnout has made 
oncologists question their training, practices, and started the dialogue centered on 
creating a healthier environment for the physicians and patients, which will be analyzed 
in the discussion.  
The Impact of Biotechnology 
Pharmaceutical Drug Costs 
 As previously mentioned, one cause of a physician’s diminished personal 
accomplishment stems from the inability to provide adequate psychological care.  The 
cost of treatment is an aspect of cancer care that causes the patient mental and physical 
duress in the form of financial distress (FD) (Delgado-Guay et al., 2015).  While 
oncologists worry about not meeting patients’ expectations concerning treatment 
outcomes, more focus needs to be placed on the impact of FD on the suffering and 
quality of life of advanced cancer patients, which could improve the health of the patient 
and decrease physician burnout (Delgado-Guay et al., 2015).   
After cancer patients identified finances as the “second most frequent source of 
distress” in a prior study, Delgado-Guay et al. conducted a cross-sectional study to 
further evaluate these claims (Kendall et al., 2011).  The researchers interviewed 149 
advanced cancer patients in the United States, and “more than 30% rated FD to be more 
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severe than physical, family, and emotional distress” (Table 5) (Delgado-Guay et al., 
2015).  Additionally, the FD correlated to increased rates of anxiety, depression, and poor 
quality of life (Delgado-Guay et al., 2015).  The results suggest that incorporating 
supportive counseling to address the FD as part of the psychosocial concerns of a patient 
could lead to improved overall health.  
 
Table 5. Perception of the impact of financial distress on other clinical problems among advanced cancer 
patients.  Taken from Delgado-Guay et al., 2015.
 
 
After acknowledging the negative health correlations associated with FD, it is 
important to understand the reasons for high drug expenses as well as how physicians are 
attempting to determine the cost-effectiveness of certain treatments and how to decrease 
costs.  Oncologists have noted, “ the average price of cancer drugs for about a year of 
therapy increased from between $5000 and $10,000 before 2000 to more than $100,000 
by 2012, while the average household income has decreased by about 8% in the past 
decade” (Kantarjian & Rajkumar, 2015).  However, it is important to note that the depth 
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and process of drug research and development is a multifaceted subject, and will not be 
fully discussed in this thesis.    
In the United States, patients pay around 20% to 30% of the total costs that 
amount to $20,000 to $30,000 per year for one drug, which is about half of the average 
annual income (Kantarjian & Rajkumar, 2015).  Through taking the ethically contractual 
Hippocratic Oath, oncologists understand that it is their moral duty to campaign for 
affordable cancer drugs: “High drug prices make them unaffordable and inaccessible, 
thus causing harm to patients and injustice when differential therapies are applied on the 
basis of affordability” (Kantarjian & Rajkumar, 2015). 
From the perspective of the pharmaceutical companies, there are a few routine 
answers given when justifying the inflated prices: 
(1) High cost of research and drug (R&D) development, (2) comparative benefits 
to patients, (3) mercatus vult--market forces will settle prices to reasonable levels, 
and (4) controlling prices stifles innovation (Kantarjian & Rajkumar, 2015). 
 
Oncologists have refuted the validity of each point as follows.  First, they have cited that, 
while the estimated R&D figure is around one billion, the costs have been evaluated to be 
as low as 10% of that figure (Light & Warburton, 2011).  Second, in regards to 
comparative benefits, “one drug may prolong life by years and another by days, yet both 
carry similar price tags” (Kantarjian & Rajkumar, 2015).  Third, economic experts have 
stated that the pharmaceutical market is an oligopoly: similar drugs are present for the 
same cancer indications, but their competition is rarely based on price (Stiglitz, 2012).  
Fourth and finally, they challenge that high drug costs might actually stifle innovation:  
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With high prices available to every new drug for cancer, companies are stumbling 
over one another in a race down a well-trodden molecular road to profits.  That 
makes pursuing high-risk innovation a less attractive option, even though that will 
be how we get novel drugs that tackle unmet needs (Bach, 2014). 
 
Therefore, while pharmaceutical companies have attempted to uphold their assertion of 
high oncological drug costs, the previous studies have attempted to prove their reasons 
fallible.  
 In order to determine how oncologists perceive costs of cancer treatments and, 
consequently, how the price factors into their treatment recommendations, Nadler et al. 
surveyed 138 clinical academic oncologists.  The majority of respondents agreed that, 
“patient ‘out-of-pocket’ drug costs influence treatment recommendations,” and “every 
patient should have access to effective cancer treatments” (Table 6).  However, 58.9% of 
oncologists opposed the following statement: “The cost of new cancer drugs influence 
treatment recommendations” (Table 6) (Nadler et al., 2006).  Hence, oncologists take into 
account the financial impact on the patient, even though they believe treatments should 
be available regardless of cost. 
 
Table 6. Role of costs in clinical decisions.  Taken from Nadler et al., 2006.
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In regards to perceived costs, the oncologists were asked to look at the cost 
effectiveness of a hypothetic treatment scenario.  By using tools such as cost-
effectiveness ratios (C/E ratios), the researchers were able to determine the life-
expectancy gain that would justify a treatment price in order to be recommended by an 
oncologist.  Nadler et al. concluded, “Sixty-two percent of respondents believed that a 
life-expectancy gain of at least 2–4 months justified the use of a hypothetical novel agent 
that cost $70,000 per year above the standard of care” (Table 7).  While oncologists’ 
cost-effectiveness thresholds are much higher than the typical $50,000, the standard for 
clinical interventions, most still require a minimum life-expectancy gain in order to 
suggest the treatment option (Nadler et al., 2006).  It should be comforting to patients 
that oncologists do their best to take cost into account when assessing treatments, and to 
know that physicians are advocating to reduce drug costs, which will be further analyzed 
in the discussion.  
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Table 7. Implied cost-effectiveness ratios for hypothetical scenario. Taken from Nadler et al., 2006.
 
 
Information Overload 
If physicians want to be able to counsel their patients on what treatment they 
believe to be the most effective, oncologists must keep current with the latest published 
studies.  With seven million pages of information added to the Internet daily, it has 
become increasingly difficult for doctors to efficiently gather new data without feeling 
overwhelmed (Hall & Walton, 2004).  This has led to an age of information overload:  
A phenomenon of urban life where people shield themselves from indiscriminate 
suggestibility to protect themselves from an overload of sensations, which results 
in an incapacity … to react to new situations with the appropriate energy” 
(Wurman, 1991). 
 
Information overload occurs when one has potentially advantageous information, but 
receiving it becomes more of a hindrance than help.   
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Another perception is that “the problem of information overload is not so much as 
an actual overload but as symptom of the failure to create high quality or value added 
information from the large amounts of information available” (Hall & Walton, 2004).  
Four factors that add to the feeling of information overload have been noted: 
(1) More diverse and increasing amounts of available information; (2) effect of 
new information and communication technologies; (3) changing nature of work 
with the new emphasis on interdisciplinary and collaborative work which both 
require greater communication; (4) end users now search for information rather 
than an intermediary (Bawden, 2001). 
 
In regards to the health care system, the rising amount of journals being published as well 
as the ease provided by electronic medical records in accessing large amounts of patient 
data have aided to the diversity and available amount of information (Hall & Walton, 
2004). 
 The time constraints placed on physicians is not a new issues; however it is more 
pressing now due to the increased expectations that come with great knowledge.  In 1997, 
the trend of information overload was being studied, and Hunt & Newman concluded 
physicians in a variety of practices reported less available time to spend reading medical 
journals (Table 8).  This study was done when the World Wide Web was less than a 
decade old, and that form of information transfer has exploded since then. 
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Table 8. Time available for reading medical journals by groups (percent of respondents).  Taken from Hunt & 
Newman, 1997.
 
  
A more recent study was conducted by Alison Bullock to determine whether 
current technology and the associated influx of information helps physicians uphold the 
following aspects of the Hippocratic Oath: “the hard-won scientific gains of those 
physicians in whose steps I walk and sharing such knowledge as is mine with those who 
are to follow” (Bullock, 2013).  Through the use of specific medical apps and immediate 
internet access, she notes that the use of mobile phones in the healthcare environment has 
allowed doctors to access searchable libraries of medical texts, dosage calculators, and 
look up drug interactions (Bullock, 2013).  Importantly, with constant updates to 
information on top of the base amount physicians are required to know, “it is simply 
unrealistic to expect doctors to recall all relevant information, particularly in stressful 
situations” (Bullock, 2013).   
While some technological advances, such as smartphones, are helpful in 
combating information overload, it is not an easy fix.  As previously mentioned, the 
increased quantity does not correlate to better quality information; in fact, since it is 
easier for people to publish their own ideas and thoughts online without academic 
censorship, it becomes more worrisome in terms of determining quality.  The problem 
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that physicians and medical students face is not finding an answer, but finding the best 
answer after learning how to discard the lesser material.  The education regarding how to 
address information overload in medical school will be further examined in the 
discussion.  
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DISCUSSION 
Burnout 
Strategies to Decrease Burnout 
 
 In a forum to discuss caring for caregivers at Massachusetts General Hospital, Dr. 
Carol Picard suggested being present in the moment might be the first step in combating 
burnout: “there is a Buddhist proverb that says, ‘Movement creates life. Stillness creates 
love. To be still and still moving, this is everything.’ Mindfulness can be a path to finding 
your center again” (Penson, Dignan, Canellos, Picard, & Lynch, 2000, p. 427). With the 
understanding that improvements and changes must occur in personal aspects of life, 
physicians also declared that they wanted to see modifications in the four following 
areas:  
(1) Training, information, and education including fellowship training, grand 
rounds, and the availability of fact sheets; (2) Acknowledgement and validation of 
grief including normalizing grief, having forums to share experiences, supportive 
mentorship, and group debriefing sessions; (3) Institutional psychosocial support 
including access to professional help and the nursing care model; and (4) 
Vacations and sabbaticals (Granek, Mazzotta, Tozer, & Krzyzanowska, 2012, p. 
2627).   
 
Research has been conducted on the usefulness of debriefing and sharing of grief with 
other oncologists, and it has been show to lower levels of EE and DP (Stafford & Judd, 
2010). There was no normalization of sadness in the oncology ward and doctors felt that 
grief in a medical setting was considered shameful and improper: “I can’t think of where 
in any of my training where people talked about feelings. ... I think you need to learn that 
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these are normal feelings, and I don’t think we ever talked about our feelings in medical 
school” (Granek, Mazzotta, Tozer, & Krzyzanowska, 2012, p. 2629).  
Studies have demonstrated that burnout and depression infiltrate the medical 
profession starting when the eager student matriculates into medical school and commits 
him or herself to a life of dedication to his or her patients, thereby instituting self-
deterioration (Tanriverdi, 2013). Granek et al. suggest that medical schools and hospitals 
have the opportunity and responsibility to support doctors in regards to proper training 
and normalizing grief in medical environments.  Oncologists explained that their current 
knowledge of grief management was a result of emulating their senior colleagues, people 
who also lack the means for correct expression. A junior oncologist articulated interest in 
a mentorship program and the benefits of filling both roles at different times: “I think it’s 
also important whenever you can also be the one who listens.  I would be interested in 
kind of like a mentoring sort of process as I move along” (Granek, Mazzotta, Tozer, & 
Krzyzanowska, 2012, p. 2630).  
 In addition to utilizing grief support, art therapy has been recommended as 
another reduction strategy.  Simona Italia et al. conducted a study to determine the 
usefulness of art therapy as a possible treatment for burnout in oncology units.  The level 
of burnout was measured through the MBI in doctors and nurses in an adult oncology 
unit (Group A) and a pediatric oncology unit (Group B).  The data analysis showed 
statistically significant differences in all dimensions (EE, DP, and PA): Group A had 
higher levels of EE and DP as well as lower levels of PA, which correlated to a medium-
high level of burnout, while Group B presented with a medium-low level of burnout 
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(Table 9) (Italia et al., 2008).  The researchers stated that the differences between the 
groups could be attributed to the age of patients treated, noting “a diagnosis of cancer for 
an adult often means expectation of death while greater hopes of definitive cure remain 
with children; the behavior of the medical personnel changes as a consequence, animated 
by greater motivation when clinical expectations are better” (Italia et al., 2008).   
 
Table 9. Differences between Groups A and B at MBI dimensions.  Taken from Italia et al., 2008. 
 
 
 After the initial diagnostic phase, twenty participants from Group B participated 
in group art therapy as a means of non-psychotherapeutic support in order to increase 
collaboration.  The members attended thirteen meetings over a four-month period, which 
involved using psychodrama techniques to encourage communication, play therapy to 
create a sense of comfort, and Ericksonian relaxation techniques (Italia et al., 2008).  The 
MBI test was re-administered at the conclusion of the therapy, which showed a 
statistically significant decrease in burnout: there was a decrease in EE and DP as well as 
an increase in PA (Table 10) (Italia et al., 2008).  However, the researchers noted that the 
positive results of art therapy cannot prove a direct causation in decreased burnout due to 
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the following confounding factors: “participation in group activity itself, the search for 
mutual support, the teamwork experience, and the chance to ask for help” (Italia et al., 
2008).  Nevertheless, art therapy could provide willing oncologists with an additional 
outlet to improve their wellbeing. 
 
Table 10. Differences at MBI dimensions in group B (n=20) in response to group art therapy.  Taken from Italia 
et al., 2008.
 
 
Oncologists themselves have provided their colleagues and superiors with advice 
and suggestions on how to cope with burnout (Table 11), who have ultimately advised 
balance as the solution: “Trying to find balance in all aspects of happiness is near 
impossible, but in and of itself, that impossibility does not make the pursuit worthless”  
(Jacobs, Clemons, & Joy, 2015).  However, whether the changes are implemented or the 
physicians listen and take their own recommendations is based solely on one aspect: time. 
No member of humanity is ever satisfied with their limited time, especially doctors in a 
field where most of their patients have very little time left. Even if oncologists had the 
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ability to work every hour of the day, and most seem to think they can overcome their 
inherent biological need to sleep with an increased intake of caffeine, they would never 
be satisfied with what they accomplished. Dr. Laurie Lyckholm extends her advice to 
troubled, broken oncologists:  
Read and study theology, philosophy, and metaphysics, to help identify the things 
that make you most uncomfortable. Separate things you can’t influence from 
those you can. Remember than many things are beyond your control. Change your 
inner dialogue from one of self-criticism to one of thankfulness and wonder 
(Lyckholm, 2007, p. 2).  
 
Table 11.  Tips to enhance the happiness of oncologists.  Taken from Jacobs et al., 2015.
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Change in Communication 
While the above suggestions cater to the needs of the physician to decrease 
burnout, there have been recent studies to gauge patient preferences regarding end of life 
care as well as the development of step-by-step protocols for delivering bad news.  
Through exploration of these topics, an understanding of what patients wish to hear and 
how to properly approach the subject will give physicians more confidence thereby 
reducing burnout associated with EOL care. 
In order to preserve patients’ hope, studies have shown that a person-centered 
approach to communication is necessary (Grassi, 2015; Umezawa et al., 2015).  The 
following aspects create the constitution of the psychosocial model wanted by patients: 
“patients’ preferences are examined, questions are answered, information is openly and 
honestly delivered, psychosocial issues are explored, and emotional support is provided” 
(Grassi, 2015).  While some might see these as ingrained aspects of oncology, mildly 
deviating from these behaviors quickly deteriorates the hope of the dying patient.  For 
example, patients noted that physicians who appeared nervous or uncomfortable, 
consulted with the family first regarding the prognosis, or those who used euphemisms 
did not promote hope through their EOL communication (Grassi, 2015). 
Additionally, part of the individualized approach should include understanding 
the culture background of the patient (Grassi, 2015; Singh et al., 2015; Umezawa et al., 
2015).  Grassi notes, “culture molds the patients’ views and their cognitive, emotional, 
and behavioral responses to cancer and cancer treatment, including the transition to 
palliative care.”  In the study of the preferences of Japanese cancer patients, Umezawa et 
 38 
al. found that only 11% of patients endorsed the following statement: “ I would like my 
physician to touch my hand or shoulder.”  While patients in the United States might find 
comfort from such a gesture, other aspects of communication console those in Japan, 
such as, “explaining how their life expectancy influences future plans” (Umezawa et al., 
2015).  Finally, studies have shown that 50% of patients with advanced stage cancer in 
Italy were not aware of their prognosis nor did they fully understand the purpose of 
treatment due to cultural reasons (Costantini et al., 2015; Grassi, 2015).  If physicians can 
understand the cultural barriers preventing the patient from grasping the details presented 
in their conversations, the EOL discussion can be more beneficial for both parties. 
Since both patients and physicians require a change in the current approach to 
delivering bad news, the SPIKES protocol has been developed to aid those conversations 
(Table 12) (Baile et al., 2000; Jacques et al., 2011).  Researchers have found that, by 
using SPIKES, it fulfills the four goals of divulging a negative prognosis: “gathering 
information from the patient, transmitting the medical information, providing support to 
the patient, and eliciting the patient's collaboration in developing a strategy or treatment 
plan for the future” (Baile et al., 2000).  With keeping those goals and SPIKES protocol 
in mind, studies have shown that a combination of didactic lectures with role-play 
between attending and resident physicians using such tools showed “an increase in 
perceived confidence by residents and statistically significant improvement in the 
delivery of bad news by external evaluators” (Jacques et al., 2011).  Providing physicians 
with not only tools to boost their conversational confidence, but also the expectations of 
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what their patients need during their end of life care transition should increase the well 
being for all of the involved individuals.  
Table 12. SPIKES protocol.  Taken from Jacques et al., 2011.
 
 
Biotechnology 
 Cost Reduction  
 As previously stated, another way to better the health of patients is by reducing 
costs of cancer treatments.  The rising cost of care is partially due to “unnecessary use of 
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health care resources” (Schnipper et al., 2012).  Dr. Howard Brody has suggested that the 
first step to cost reform is using “evidence-based guidelines” when ordering tests and 
treatments: “physicians in lower-cost regions order and provide evidence-based tests and 
treatments just as often as their higher-cost colleagues do, but they tend to avoid 
providing care whose usefulness is not well supported by existing evidence” (Brody, 
2010).   
In order to help physicians makes these decisions more succinctly, the American 
Society of Clinical Oncology Task Force on the Cost of Cancer Care created a 
methodology to identify “five tests or procedures commonly used in their field whose 
necessity is not supported by high-level evidence” (Schnipper et al., 2012).  This top five 
list should be consulted before ordering any tests or treatments for cancer patients: 
(1) Do not use cancer-directed therapy for patients with solid tumors who have 
the following characteristics: low performance status (3 or 4), no benefit from 
prior evidence-based interventions, not eligible for a clinical trial, and with no 
strong evidence supporting the clinical value of further anticancer treatment; (2) 
Do not perform PET, CT, and radionuclide bone scans in the staging of early 
prostate cancer at low risk for metastasis; (3) Do not perform PET, CT, and 
radionuclide bone scans in the staging of early breast cancer at low risk for 
metastasis; (4) Do not perform surveillance testing (biomarkers) or imaging (PET, 
CT, and radionuclide bone scans) for asymptomatic patients who have been 
treated for breast cancer with curative intent; (5) Do not use white cell–
stimulating factors for primary prevention of febrile neutropenia for patients with 
less than 20% risk for this complication (Schnipper et al., 2012). 
 
While each point will not be fully analyzed, it is important to note that use of these 
practices is currently overvalued and not supported in regards to evidence of clinical 
benefit, and by following this protocol, individual patient costs can be decreased 
accordingly. 
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 In addition to looking at changes that can be made in health care choices, 
physicians have offered possible solutions to the inflated drug prices.  After analyzing the 
reasons behind the costs, Kantarjian & Rajkumar produced multiple options for reduction 
of costs: 
(1) Allow Medicare to negotiate drug prices, (2) develop cancer treatment 
pathways/guidelines that incorporate the cost-benefit of cancer drugs (drug 
"value"), as occurs today in many other countries, (3) allow the US FDA or 
physician panels to recommend target prices based on the magnitude of benefit 
(value-based pricing), as is practiced in many other developed countries, (4) 
eliminate "pay-for-delay" strategies, (5) allow the importation of drugs from 
abroad for personal use, (6) allow the Patient-Centered Outcomes Research 
Institute and other cancer advocacy groups to consider cost in their 
recommendations, and (7) most importantly, create patient-driven grassroots 
movements and organizations (as happened during the AIDS epidemic) to 
advocate effectively for the interests of patients with cancer (Kantarjian & 
Rajkumar, 2015). 
 
It is important to realize that the researches have pointed out that many of their 
suggestions have already been implemented in numerous countries besides the United 
States. Additionally and unfortunately, Kantarjian & Rajkumar noted that patients might 
be the best advocates in the for-profit market.  Hopefully as oncologists realize they have 
sworn to protect patients from harm and injustice, they will become an unfailing force in 
the fight for reduction of cancer prices.  
Finally, the responsibility also falls on the shoulders of the pharmaceutical 
companies, who all have mission statements to help the patients they are serving.  
Oncologists demand that these companies  “should also be judged by their corporate 
social responsibility” (Kantarjian & Rajkumar, 2015).  Fortunately, an access to medicine 
index has been created: “[it] rank[s] research-based pharmaceutical companies' efforts to 
make products available, affordable, and accessible” (Kantarjian & Rajkumar, 2015).  
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This provides consumers with a “valuable moral scale,” which can be applied to 
oncological drugs.  However, depending on the type of cancer and associated necessary 
treatments, patients and oncologists might be presented with limited options.  
Nevertheless, demanding moral responsibility and being able to judge pharmaceutical 
companies on their progress is a step in the right direction for patients to receive the care 
they deserve but cannot afford. 
 
Consolidation of Information 
 To protect physicians and medical students from information overload, 
suggestions have been made concerning information consolidation.  Current literature 
points to four areas that can be explored for possible solutions: “technical, individual 
strategy, organizational strategy and human agent intervention” (Hall & Walton, 2004).  
While technical solutions “focus on the creation of software/hardware solutions to the 
storage and dissemination of information/knowledge,” physicians are still lacking a 
central database that has successful fulfilled those needs (Hall & Walton, 2004).  
Researchers are currently working on solutions to those issues, but they required more 
exploration of how to best consolidate the constant influx of information. 
  However, others have suggested that it is not the job of technology to produce a 
solution to this dilemma.  Instead, researchers promote ideas for the each physician to 
utilize: “Individuals should look to techniques such as improved time and load 
management to solve information overload rather than look for technological solutions” 
(Hall & Walton, 2004).  Regrettably, physicians are already facing time constraints due 
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to their increased caseloads, so trying to utilize personal time to perform their own 
consolidation of information might not be possible.  Additionally, other studies have 
considered the importance of the organization of the data: “The efficient use of 
information and knowledge depends not just on technology, either as storage or delivery, 
but that there is the correct organizational structure in place to take advantage of that 
knowledge/information” (Hall & Walton, 2004).  Finally, the last solution that has been 
suggested is the use of a librarian to combat and evaluate the increasing amounts of 
knowledge:  
Various potential benefits of using a human agent in mediating the problems of 
the information intense workplace that is the National Health Service have been 
described.  Although not explicitly dealing with information overload, it is 
proposed that the librarian was in a prime position to work with clinicians by 
reprocessing and rerouting information to others in the hospital community. 
[Researchers] argue persuasively that clinical librarianship can be seen as an 
attempt to solve the twin problems of information overload and the 
implementation of evidence-based practice (Hall & Walton, 2004).   
 
While individually these suggestions might not provide complete solutions, a 
combinatorial effect might be a useful direction to pursue.   
 The last issue that needs to be addressed is how to educate medical students on 
finding the quality medical information within the quantity.  Researchers have correctly 
identified the problem: “There is a confusion between having the ability to use hardware, 
software, and applications and holding the knowledge, vocabulary and information 
literacy to deploy the technology with care and rigor” (Ghezzi, Chumber, & Brabazon, 
2014).  While the use of Google will produce millions of results in seconds, Ghezzi et al. 
make the point that the immediately accessible information, which is available to 
everyone, is only useful if students are able to critically evaluate it.  To aid in the quality 
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appraisal, there are various tools at the disposal of the students, which are placed into five 
categories: “codes of conduct (e.g., American Medical Association), quality labels [e.g., 
Health On the Net Foundation (HON) code], user guidance systems (e.g., DISCERN), 
filtering tools [e.g., OMNI], and third-party quality and accreditation labels [e.g., 
Utilization Review Accreditation Commission (URAC)]” (Ghezzi, Chumber, & 
Brabazon, 2014).  The next step is teaching students how to use these to their benefit to 
decrease the amount of information overload. 
Finally, researches have made a point to address the increasing Internet literacy 
within the patient population:   
Students will have to face patients that will have collected large amounts of 
unreliable and unverified information. There is confusion between the ability to 
use a search engine and the capacity to interpret the returned results. To build a 
good relationship they must be prepared to discuss them with the patient rather 
than just dismissing all of them en bloc (Ghezzi, Chumber, & Brabazon, 2014). 
 
If the students understand how to discriminate between the information, it provides them 
with an additional tool when conversing with patients.  They will become the future 
generation of physicians who can appreciate that patients will scour the Internet for every 
statistic related to their disease, and possess the ability to explain why a piece of 
information is more relevant and better quality than others in its field. 
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CONCLUSIONS 
After analyzing the various plights felt by physicians and oncologists specifically, 
there is a wealth of information supporting the need for changes in multiple areas of the 
medical profession.  In generalized terms, the current biotechnology platform needs to be 
revolutionized in terms of costs and presentation of information.  Most importantly, the 
psychological wellbeing of physicians needs to be addressed sooner and more often, not 
only for the happiness of the doctor, but also for the correlated improvement in health of 
the patients. 
Due to the high prevalence of suicidal ideation and thoughts of leaving medical 
school felt by current medical school students, physicians are starting to regard warnings 
about the importance of positive mental health starting at the beginning of their 
education.  To decrease burnout that is already occurring at the institutional level, 
physicians suggest, “formalization of self-care as a core competency within the United 
States could further stimulate curricula innovation and evaluation to advance evidence-
based approaches to equip trainees and physicians with skills that promote mental health 
and resilience (Dyrbye et al., 2012).   
There has to be a shift in the mental mindset of current oncologists and those 
interested in the field must be properly counseled.  They must take heed and learn to 
embody the words sworn by all medical professionals in the Hippocratic Oath:  
 
I swear to fulfill, to the best of my ability and judgment, this covenant: 
I will respect the hard-won scientific gains of those physicians in whose steps I 
walk, and gladly share such knowledge as is mine with those who are to follow. 
I will apply, for the benefit of the sick, all measures, which are required, avoiding 
those twin traps of overtreatment and therapeutic nihilism. 
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I will remember that there is art to medicine as well as science, and that warmth, 
sympathy, and understanding may outweigh the surgeon's knife or the chemist's 
drug. 
I will not be ashamed to say "I know not," nor will I fail to call in my colleagues 
when the skills of another are needed for a patient's recovery. 
I will respect the privacy of my patients, for their problems are not disclosed to 
me that the world may know. Most especially must I tread with care in matters of 
life and death. If it is given me to save a life, all thanks. But it may also be within 
my power to take a life; this awesome responsibility must be faced with great 
humbleness and awareness of my own frailty. Above all, I must not play at God. 
I will remember that I do not treat a fever chart, a cancerous growth, but a sick 
human being, whose illness may affect the person's family and economic stability. 
My responsibility includes these related problems, if I am to care adequately for 
the sick. 
I will prevent disease whenever I can, for prevention is preferable to cure. 
I will remember that I remain a member of society, with special obligations to all 
my fellow human beings, those sound of mind and body as well as the infirm. 
If I do not violate this oath, may I enjoy life and art, respected while I live and 
remembered with affection thereafter. May I always act so as to preserve the 
finest traditions of my calling and may I long experience the joy of healing those 
who seek my help (Lasagna, 1964). 
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